Answers are grounded in this paper and cite their sources.
Serum Fourier transform infrared (FTIR) spectroscopy offers a rapid and minimally invasive approach for auxiliary cancer discrimination, but distinguishing cancer types remains challenging because of spectral overlap and biological background variation. We developed a two-stage chemometric framework integrating serum FTIR spectra with routine biochemical indices to distinguish healthy controls, colorectal cancer and lung cancer. The study included 364 serum samples from 64 healthy controls, 160 patients with colorectal cancer and 140 patients with lung cancer. In the first stage, colorectal and lung cancer samples were pooled into a single cancer group for discrimination from healthy controls; in the second stage, cancer samples were further classified as colorectal or lung cancer. For the same three-class task, the FTIR-only model achieved a macro-F1 score of 0.982, compared with 0.746 for the best biochemical-only model. The complete hierarchical model achieved a primary saved-OOF accuracy of 0.9973 and a macro-F1 score of 0.9963, with one healthy control misclassified as colorectal cancer and no cancer sample missed. These results are internal estimates because preprocessing and feature selection were not refitted within the inner stacking folds; fully nested reanalysis and independent external validation are needed before clinical application.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: